These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 27801288)

  • 21. Evaluating the safety and efficacy of silymarin in β-thalassemia patients: a review.
    Moayedi Esfahani BA; Reisi N; Mirmoghtadaei M
    Hemoglobin; 2015; 39(2):75-80. PubMed ID: 25643967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major.
    Prati D
    Vox Sang; 2000; 79(3):129-37. PubMed ID: 11111230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.
    Saliba AN; El Rassi F; Taher AT
    Expert Rev Hematol; 2016; 9(2):151-68. PubMed ID: 26613264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current approach to iron chelation in children.
    Aydinok Y; Kattamis A; Viprakasit V
    Br J Haematol; 2014 Jun; 165(6):745-55. PubMed ID: 24646011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathophysiology of transfusional iron overload.
    Porter JB; Garbowski M
    Hematol Oncol Clin North Am; 2014 Aug; 28(4):683-701, vi. PubMed ID: 25064708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial fibrillation in β-thalassemia patients with a focus on the role of iron-overload and oxidative stress: A review.
    Nomani H; Bayat G; Sahebkar A; Fazelifar AF; Vakilian F; Jomezade V; Johnston TP; Mohammadpour AH
    J Cell Physiol; 2019 Aug; 234(8):12249-12266. PubMed ID: 30536543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA Damage in Chronic Kidney Disease: Evaluation of Clinical Biomarkers.
    Schupp N; Stopper H; Heidland A
    Oxid Med Cell Longev; 2016; 2016():3592042. PubMed ID: 27313827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein antioxidants in thalassemia.
    Awadallah S
    Adv Clin Chem; 2013; 60():85-128. PubMed ID: 23724742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A storm in the niche: Iron, oxidative stress and haemopoiesis.
    Pilo F; Angelucci E
    Blood Rev; 2018 Jan; 32(1):29-35. PubMed ID: 28847531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity.
    Boshuizen M; van der Ploeg K; von Bonsdorff L; Biemond BJ; Zeerleder SS; van Bruggen R; Juffermans NP
    Blood Rev; 2017 Nov; 31(6):400-405. PubMed ID: 28755795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron overload in hematological disorders.
    Fibach E; Rachmilewitz EA
    Presse Med; 2017 Dec; 46(12 Pt 2):e296-e305. PubMed ID: 29174474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of redox iron towards an increase in mortality among patients: a systemic review and meta-analysis.
    Sharma S
    Blood Res; 2019 Jun; 54(2):87-101. PubMed ID: 31309086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labile iron in cells and body fluids: physiology, pathology, and pharmacology.
    Cabantchik ZI
    Front Pharmacol; 2014; 5():45. PubMed ID: 24659969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron-mediated tissue damage in acquired ineffective erythropoiesis disease: It's more a matter of burden or more of exposure to toxic iron form?
    Pilo F; Cilloni D; Della Porta MG; Forni GL; Piperno A; Santini V; Angelucci E
    Leuk Res; 2022 Mar; 114():106792. PubMed ID: 35091283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of anaemia in oxidative and genotoxic damage in transfused β-thalassaemic patients.
    Ferro E; Visalli G; La Rosa MA; Civa R; Papa GR; D'Ascola DG; Roccamo G; Piraino B; Salpietro C; Di Pietro A
    Hematology; 2017 Apr; 22(3):183-191. PubMed ID: 27801288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron and oxidative stress in cardiomyopathy in thalassemia.
    Berdoukas V; Coates TD; Cabantchik ZI
    Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusional iron overload and iron chelation therapy in thalassemia major and sickle cell disease.
    Marsella M; Borgna-Pignatti C
    Hematol Oncol Clin North Am; 2014 Aug; 28(4):703-27, vi. PubMed ID: 25064709
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.